The ACCC project, Multidisciplinary Multiple Myeloma Care, is an education series designed to support the cancer care team in diagnosing, testing, and treating patients with multiple myeloma.
The series includes a webinar that recaps key multiple myeloma sessions from ASCO 2018, and three regional educational programs developed in conjunction with clinicians who have deep expertise in caring for patients with multiple myeloma.
This one-hour webinar reviews data and key findings from selected abstracts that were presented in the category of Hematologic Malignancies—Plasma Cell Dyscrasia at the American Society of Clinical Oncology (ASCO) Annual Meeting in June 2018. Dr. David Vesole shares his expertise as it pertains to these findings.
David Vesole, MD, PhD, FACP, John Theurer Cancer Center at Hackensack University Medical Center
The multiple myeloma Regional Lecture Series highlights ways to tailor care plans and effectively manage patients with high-risk profiles, summarizes guideline recommendations for prevention and management of skeletal-related events, and outlines the importance of the multidisciplinary, team-based approach to care. As representatives of their regions, speakers also address how they meet the unique needs of the communities they serve.
Speaker: Yogesh S. Jethava, MBBS, FACP, University of Iowa Hospitals & Clinics
Speaker: Abhinav B. Chandra, MD, Yuma Regional Medical Center Cancer Center
This breakfast session was part of #ACCCNOC, held from October 17-19 in Phoenix, Arizona. Dr. Abhinva Chandra presents a case study, as well as details on delivery of the multidisciplinary care for multiple myeloma in the community setting, strategies for care coordination with a "snowbird" population, managing skeletal-related events, and patient education.
Speaker: Tomer Mark, MD, MSc, University of Colorado School of Medicine
This fall symposium featured guest speaker Dr. Tomer Mark who presented critical information on managing the toxicities associated with multiple myeloma therapy.
Funding & support provided by Amgen Oncology